Jefferies cuts Zentalis stock target to $2.50; maintains hold
Jefferies analyst Akash Tewari adjusted the price target for Zentalis Pharmaceuticals (NASDAQ:ZNTL), bringing it down to $2.50 from the previous figure of $6.00, while reiterating a Hold rating on the ...
Jefferies raises PT on internet stocks, sees AI opening new investment paths
Jefferies said AI advancements could create fresh investment opportunities beyond hyperscalers, as it highlighted companies like Reddit and Uber (NYSE:UBER) as key beneficiaries. The brokerage remains ...
sbcnews.co.uk18h
Analysts at ICE2025 highlight early Brazil Bets challenges & opportunities
JMP Securities provided new insights on the initial launch of the Brazil Bets market, in which operators appear cautious to ...
Jefferies Reaffirms Their Buy Rating on Atlas Arteria (MAQAF)
Jefferies analyst Anthony Moulder maintained a Buy rating on Atlas Arteria (MAQAF – Research Report) today and set a price target of A$6.31.
Jefferies Sticks to Their Buy Rating for PG&E (PCG)
In a report released yesterday, Julien Dumoulin Smith from Jefferies maintained a Buy rating on PG&E (PCG – Research Report), with a price ...